Balance Sheet Data

Myriad Genetics, Inc. (MYGN)

$22.81

-0.50 (-2.15%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 180.60136.90217.80339.80114.90184.59180.49176.48172.56168.73
Total Cash (%)
Account Receivables 102.10138.607191.30101.6090.9688.9486.9785.0383.15
Account Receivables (%)
Inventories 34.3031.4029.1015.3020.1023.6123.0822.5722.0721.58
Inventories (%)
Accounts Payable 2633.3021.7029.6028.8025.3924.8324.2723.7323.21
Accounts Payable (%)
Capital Expenditure -8.40-8.60-10.20-18-45.30-17.18-16.80-16.42-16.06-15.70
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.